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219* Lung clearance index: wash-in data compared to wash-out data
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Leuven, Pediatric Pulmonology, Leuven, Belgium; 2University Hospital Leuven,
Leuven, Belgium
Lung clearance index (LCI) is a sensitive marker of early CF lung disease. It is
a non-invasive but time consuming test. When using an inert gas such as Helium
or SF6 the wash-in phase is followed by a washout phase. For routine follow up it
would be useful if the test duration could be shortened to the wash-in phase only.
We therefore compared test acceptability, result variability and correlation (Pearson)
when calculating LCI from CEV (cumulative exhaled volume) and FRC obtained
during wash-in and washout.
Results: 23 children with CF (age 6−17) were measured by helium multiple
breath washout (Exhalyzer D, Eco Medics) and values were compared with %FVC,
%FEV1 and %FEF25−75. Measurements did not reach quality control criteria (at
least 2 FRC values within 10% of the smallest) in 3 children for wash-in with
4 invalid washout measurements. FRC washout (liter) was smaller (p = .01) than
FRC wash-in, mean difference was −0.120 (95% CI −0.213, −0.027), but values
correlated strongly (r = 0.97; p< 0.001). Mean intra-patient CV’s for FRC washout
and wash-in were 2.52 and 3.05. Mean CEV from washout and wash-in did not
differ, mean intra-patient CV during for CEV in both phases was <3%, r = 0.853
(p< 0.001). LCI washout was higher (p = .05) than LCI wash-in, respectively 8.95
(sd 1.55) and 8.10 (sd 1.21), r = 0.62 (p = 0.008). All patients with LCI< 7 (washout
or wash-in) had normal %FVC, %FEV1 and %FEF25−75 but not vice versa.
Conclusion: in CF children valid LCI measurements can be calculated from the
wash-in phase. They strongly correlate with LCI washout values. Therefore LCI
measurement technique can potentially be simpliﬁed and shortened.
220* Transition of lung function from infants to children with
cystic ﬁbrosis (CF), evaluated by whole-body plethysmography
R. Kraemer1, C. Cripe-Mamie2, W. Tennhoff2, U. Bu¨hlmann3, S. Gallati4.
1University Children’s Hospital, Department of Paediatrics, Berne, Switzerland;
2University Children’s Hospital, Department of Paediatrics, Berne, Switzerland;
3Children’s Hospital, Stadtspital Triemli, Zu¨rich, Switzerland; 4Univerity Children’s
Hospital, Division of Human Genetics, Berne, Switzerland
We aimed to evaluate the onset of functional characteristics during infancy with
follow-up during childhood, as well as to determine the physiological factors of
lung function predominantly inﬂuencing these mechanisms in relation to geno-
types. Lung function was assessed by infant whole-body plethysmography in
66 infants (30 males, 36 females) with CF at ages 6 to 21 months pertaining
to functional residual capacity (FRCpleth) and effective airway resistance (sReff ),
as well as by whole-body plethysmography and multibreath nitrogen washout
during childhood (5 to 14 years of age), featuring FRCpleth, lung clearance index
(LCI), trapped gas (VTG), sReff , and forced expiratory indices (FEV1, FEF50).
Follow-up data expressed as standard deviation scores (SDS), equal to z-scores,
were evaluated by linear mixed effects model (LMM) analysis. CF infants, who
presented with bronchial obstruction only, demonstrated later in 72.7% ventilation
inhomogeneities (LCI> 4SDS), whereas CF infants presenting with pulmonary
hyperinﬂation and bronchial obstruction were prone to develop in addition to
ventilation inhomogeneities (p< 0.001), trapped gases (p< 0.001) and gas exchange
disturbances (PaO2: p< 0.0001; PaCO2: p< 0.001) later in childhood. In regard
to genotypes, F508del(2) and F508del/3905insT presented with the highest pro-
gression in pulmonary hyperinﬂation. Moreover sReff differentiated signiﬁcantly
between all genotypes (p< 0.001), showing the highest progression in patents with
F508del/3905insT.
It is concluded that functional abnormalities assessed by infant whole-body plethys-
mography in CF infants are predictive for subsequent functional deﬁcits in later
childhood.
221* Validation of the Liverpool Respiratory Symptom Questionnaire
(LRSQ) in well children with cystic ﬁbrosis (CF)
R. Trinick1, C. Darracott1, K.W. Southern1, P.S. McNamara1. 1University of
Liverpool, Institute of Child Health, Alder Hey Children’s Hospital, Liverpool,
United Kingdom
Objectives: To assess whether a respiratory symptom questionnaire [previously
validated in a preschool population (LRSQ)] can distinguish between well children
with and without CF. Also, to examine whether LRSQ scores correlate with
Northern Chest X-ray (NCXR) score, FEV1 and Shwachman (S) score.
Methods: Parents of children with CF and healthy controls completed the LRSQ.
Children with CF were well at the time of LRSQ completion. Questions were
grouped into 8 domains and scored from “not at all” (0) to “every day” (5).
Statistical analysis used Mann–Whitney, Kendall’s rank correlation, multiple lin-
ear regression (confounders) and Cronbach’s alpha (internal consistency). Data
expressed as median [IQR].
Results: 104 children with CF had signiﬁcantly higher total LRSQ scores (17
[6−30]) compared to 182 controls (2 [0−6] p< 0.001). Scores were higher in all
domains (p< 0.001). Domain scores were higher in those children with persistent
pseudomonal carriage (p< 0.05). There was a positive correlation between total
LRSQ score and NCXR score (p< 0.01). There were negative correlations between
total score and S score (p< 0.001) and total score and FEV1 (p< 0.001). Cronbach’s
alpha scores were >0.7 in 7 of 8 domains.
Conclusions: A signiﬁcantly increased LRSQ score in children with CF, even during
a period of good health, compared to non-CF controls further validates this as a
robust tool to detect signiﬁcant respiratory disease in a paediatric population. The
ﬁnding of signiﬁcant correlation with other markers of disease severity in older CF
children suggests the potential for use of the LRSQ as a clinical tool to monitor
respiratory condition.
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Introduction: Most available symptom scores (SS) and quality-of-life question-
naires are designed for the evaluation of long-term interventions in CF. We describe
and validate a simple SS that can be used to evaluate CF acute PExs.
Patients and Methods: Symptoms evaluated were cough, sputum, breathlessness
and fatigue based on the MRC respiratory questionnaire. Each symptom was scored
from 1 to 4 according to severity, 4 being the worst. Total SS was the summation
of the scores of each symptom. SS was evaluated during PExs at the start of
IV antibiotic treatment, day 7 and end (day 14). All patients underwent spirometry
according to BTS/ARTP standards. Validation of the SS included 4 steps: internal
correlation of the components of the SS; sensitivity of the SS to change during
treatment; correlation of the total SS with FEV1, PEFR and FVC; and correlation
of changes in the total SS with changes in FEV1.
Results: 122 observations in 50 adult CF patients were analysed; mean age 25.7 y.
There was signiﬁcant correlation between the components of the SS, with the
exception of cough and breathlessness. The total SS inversely correlated with at
least one spirometry value. Breathlessness score inversely correlated with FEV1,
FVC and PEFR. Total SS improved at the end of PExs in 84.5% of cases, remained
unchanged in 5.3% and worsened in 10.2% of cases. Changes in SS inversely
correlated with changes in FEV1 (r = −0.32 P = 0.037).
Conclusions: This is a new simple SS that evaluates acute PExs in CF patients.
The majority of the components of the SS achieved internal correlation. SS was
sensitive to change during treatment. A signiﬁcant correlation was seen between
the SS and FEV1.
